In prostate cancer, PRK1 phosphorylates histone H3 at threonine 11 (H3T11) upon AR activation, facilitating AR-dependent transcription by promoting histone demethylation and RNA polymerase II recruitment. Here, AR is linked to prostate carcinoma.